Application of a deuterium replacement strategy to modulate the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a novel CRF1 antagonist.
Drug Metab Dispos
; 42(5): 954-62, 2014 May.
Article
en En
| MEDLINE
| ID: mdl-24616265
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Oxazoles
/
Pirazoles
/
Receptores de Hormona Liberadora de Corticotropina
/
Deuterio
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Humans
/
Male
Idioma:
En
Año:
2014
Tipo del documento:
Article